Brian Lenz, Chief Financial Officer at ADMA BIOLOGICS, INC. (ADMA), bought 1,000 shares at $9.15 ($9K) on 2015-12-02, disclosed to the SEC on 2015-12-03.
Open-market purchase of $9k ADMA by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.14 | 500 | $5K | 49.9% |
| 2 | $9.15 | 250 | $2K | 25.0% |
| 3 | $9.18 | 250 | $2K | 25.1% |
| Total | $9.15 avg | 1,000 | $9K | 100% |
| Filing → |
| ADMA | BUY | 2021-10-26 | $30K | — | Filing → |
| ADMA | BUY | 2020-08-12 | $12K | — | Filing → |
| ADMA | BUY | 2020-02-11 | $25K | — | Filing → |